Publications by authors named "Wayne Weng"

Claim this Profile
E
Economic value of nonsurgical weight loss in adults with obesity.
Yuchen Ding, Xiaozhou Fan, Christopher M Blanchette, B Gabriel Smolarz, Wayne Weng

J Manag Care Spec Pharm· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural Language Processing Improves Detection of Nonsevere Hypoglycemia in Medical Records Versus Coding Alone in Patients With Type 2 Diabetes but Does Not Improve Prediction of Severe Hypoglycemia Events: An Analysis Using the Electronic Medical Record in a Large Health System.
Anita D Misra-Hebert, Alex Milinovich, Alex Zajichek, Xinge Ji, Todd D Hobbs, Wayne Weng

Diabetes Care· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model.
Kevin M Pantalone, Anita D Misra-Hebert, Todd M Hobbs, Sheldon X Kong, Xinge Ji, Wayne Weng

Diabetes Care· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between shared medical appointments and weight loss outcomes and anti-obesity medication use in patients with obesity.
Kelly Shibuya, Xinge Ji, Elizabeth R Pfoh, Alex Milinovich, Wayne Weng

Obes Sci Pract· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Prevalence of Hypoglycemia in a Medical Transcription Database.
Chioma Uzoigwe, Carol Mahler Hamersky, Deborah I Arbit, Wayne Weng, Michael S Radin

Diabetes Metab Syndr Obes· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence of cardiovascular disease by vascular bed and impact on healthcare costs in a large, real-world population with type 2 diabetes.
Wayne Weng, Sheldon X Kong, Rahul Ganguly, Malene Hersloev, Jason Brett

Endocrinol Diabetes Metab· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of atherosclerotic cardiovascular disease on healthcare resource utilization and costs in patients with type 2 diabetes mellitus in a real-world setting.
Wayne Weng, Ye Tian, Sheldon X Kong, Rahul Ganguly, Malene Hersloev

Clin Diabetes Endocrinol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States.
Wayne Weng, Ye Tian, Sheldon X Kong, Rahul Ganguly, Malene Hersloev

Endocrinol Diabetes Metab· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of newer anti-obesity medications in a real-world setting.
Rahul Ganguly, Ye Tian, Sheldon X Kong, Malene Hersloev, Todd Hobbs, Wayne Weng

Diabetes Res Clin Pract· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Inertia in Type 2 Diabetes Management: Evidence From a Large, Real-World Data Set.
Kevin M Pantalone, Anita D Misra-Hebert, Todd M Hobbs, Xinge Ji, Sheldon X Kong, Wayne Weng

Diabetes Care· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease.
Kevin M Pantalone, Anita D Misra-Hebert, Todd M Hobbs, Xinge Ji, Sheldon X Kong, Wayne Weng

Cardiovasc Diabetol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of glycemic control on the Diabetes Complications Severity Index score and development of complications in people with newly diagnosed type 2 diabetes.
Kevin M Pantalone, Anita D Misra-Hebert, Todd M Hobbs, Brian J Wells, Sheldon X Kong, Wayne Weng

J Diabetes· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of glucagon-like peptide-1 receptor agonist use and rates of acute myocardial infarction, stroke and overall mortality in patients with type 2 diabetes mellitus in a large integrated health system.
Robert S Zimmerman, Todd M Hobbs, Brian J Wells, Sheldon X Kong, Michael W Kattan, Wayne Weng

Diabetes Obes Metab· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system.
Kevin M Pantalone, Todd M Hobbs, Kevin M Chagin, Sheldon X Kong, Brian J Wells, Wayne Weng

BMJ Open· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and clinical characteristics of patients with type 2 diabetes mellitus according to body mass index: findings from an electronic medical records database.
Wayne Weng, Ye Tian, Edward S Kimball, Sheldon X Kong, Jonathan Bouchard

BMJ Open Diabetes Res Care· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreasing incidence of type 2 diabetes mellitus in the United States, 2007-2012: Epidemiologic findings from a large US claims database.
Wayne Weng, Yuanjie Liang, Edward S Kimball, Todd Hobbs, Sheldon X Kong

Diabetes Res Clin Pract· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Characteristics and Treatment Patterns of Patients with Newly Diagnosed Type 2 Diabetes in a Large United States Integrated Health System between 2008 and 2013.
Kevin M Pantalone, Todd M Hobbs, Brian J Wells, Sheldon X Kong, Michael W Kattan, Wayne Weng

Clin Med Insights Endocrinol Diabetes· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Changes in Medical Services and Related Costs in a Single Cohort of Patients Newly Diagnosed With Type 2 Diabetes, 2006 to 2012.
Wayne Weng, Yuanjie Liang, Edward S Kimball, Todd Hobbs, Sheldon Kong

Clin Ther· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in the incidence of diabetes, its clinical sequelae, and associated costs in pregnancy.
Lois Jovanovič, Yuanjie Liang, Wayne Weng, Marianthe Hamilton, Lisa Chen

Diabetes Metab Res Rev· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics, complications, comorbidities and treatment patterns among patients with type 2 diabetes mellitus in a large integrated health system.
Kevin M Pantalone, Todd M Hobbs, Brian J Wells, Sheldon X Kong, Michael W Kattan, Wayne Weng

BMJ Open Diabetes Res Care· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-sparing and safety-enhancing effects of an IGF-I-based dosing regimen in short children treated with growth hormone in a 2-year randomized controlled trial: therapeutic and pharmacoeconomic considerations.
Pinchas Cohen, Wayne Weng, Alan D Rogol, Ron G Rosenfeld, Anne-Marie Kappelgaard

Clin Endocrinol (Oxf)· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prepubertal children with growth hormone deficiency treated for four years with growth hormone experience dose-dependent increase in height, but not in the rate of puberty initiation.
Alan D Rogol, Pinchas Cohen, Wayne Weng, Anne-Marie Kappelgaard, John A Germak

Horm Res Paediatr· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of IGF-based growth hormone (GH) dosing in nonGH-deficient (nonGHD) short stature children with low IGF-I is not related to basal IGF-I levels.
Pinchas Cohen, Alan D Rogol, Wayne Weng, Anne-Marie Kappelgaard, Ron G Rosenfeld

Clin Endocrinol (Oxf)· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
Pinchas Cohen, John Germak, Alan D Rogol, Wayne Weng, Anne-Marie Kappelgaard

J Clin Endocrinol Metab· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes.
Philip Raskin, Titus Gylvin, Wayne Weng, Louis Chaykin

Diabetes Metab Res Rev· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis